Detailed information for compound 38142

Basic information

Technical information
  • TDR Targets ID: 38142
  • Name: 4-chloro-5-(4-chlorophenyl)-1-(4-sulfamoylphe nyl)pyrazole-3-carboxamide
  • MW: 411.262 | Formula: C16H12Cl2N4O3S
  • H donors: 2 H acceptors: 4 LogP: 2.58 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: Clc1ccc(cc1)c1c(Cl)c(nn1c1ccc(cc1)S(=O)(=O)N)C(=O)N
  • InChi: 1S/C16H12Cl2N4O3S/c17-10-3-1-9(2-4-10)15-13(18)14(16(19)23)21-22(15)11-5-7-12(8-6-11)26(20,24)25/h1-8H,(H2,19,23)(H2,20,24,25)
  • InChiKey: NMOJAXQDSULNMZ-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 4-chloro-5-(4-chlorophenyl)-1-(4-sulfamoylphenyl)-3-pyrazolecarboxamide

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Ovis aries Cyclooxygenase-1 Starlite/ChEMBL References
Mus musculus prostaglandin-endoperoxide synthase 2 Starlite/ChEMBL References
Homo sapiens prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) Starlite/ChEMBL References
Homo sapiens prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Giardia lamblia Hypothetical protein 0.1408 0.8159 0.5
Leishmania major cytochrome P450 reductase, putative 0.1408 0.8159 0.8159
Trypanosoma brucei NADPH-dependent diflavin oxidoreductase 1 0.1588 1 1
Trichomonas vaginalis sulfite reductase, putative 0.1588 1 1
Loa Loa (eye worm) FAD binding domain-containing protein 0.0981 0.3805 0.3805
Echinococcus multilocularis NADPH dependent diflavin oxidoreductase 1 0.1588 1 1
Plasmodium vivax flavodoxin domain containing protein 0.1408 0.8159 0.8159
Trypanosoma brucei NADPH-cytochrome p450 reductase, putative 0.1588 1 1
Plasmodium vivax NADPH-cytochrome p450 reductase, putative 0.1588 1 1
Mycobacterium ulcerans formate dehydrogenase H FdhF 0.1588 1 0.5
Echinococcus granulosus NADPH dependent diflavin oxidoreductase 1 0.1588 1 1
Echinococcus multilocularis NADPH cytochrome P450 reductase 0.1588 1 1
Toxoplasma gondii flavodoxin domain-containing protein 0.0788 0.1841 0.5
Loa Loa (eye worm) FAD binding domain-containing protein 0.1588 1 1
Schistosoma mansoni 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase 0.0981 0.3805 0.2407
Leishmania major NADPH-cytochrome p450 reductase-like protein 0.1588 1 1
Trypanosoma cruzi cytochrome P450 reductase, putative 0.1588 1 1
Schistosoma mansoni NADPH flavin oxidoreductase 0.08 0.1964 0.0151
Trypanosoma brucei NADPH--cytochrome P450 reductase, putative 0.1588 1 1
Entamoeba histolytica type A flavoprotein, putative 0.0607 0 0.5
Echinococcus granulosus NADPH cytochrome P450 reductase 0.1588 1 1
Brugia malayi FAD binding domain containing protein 0.1588 1 1
Toxoplasma gondii flavodoxin domain-containing protein 0.0788 0.1841 0.5
Brugia malayi FAD binding domain containing protein 0.0981 0.3805 0.3805
Treponema pallidum flavodoxin 0.0607 0 0.5
Giardia lamblia Nitric oxide synthase, inducible 0.1408 0.8159 0.5
Trichomonas vaginalis NADPH fad oxidoreductase, putative 0.1408 0.8159 0.8159
Trypanosoma brucei NADPH--cytochrome P450 reductase, putative 0.1588 1 1
Chlamydia trachomatis sulfite reductase 0.0981 0.3805 0.5
Trypanosoma cruzi p450 reductase, putative 0.1588 1 1
Entamoeba histolytica type A flavoprotein, putative 0.0607 0 0.5
Leishmania major p450 reductase, putative 0.1588 1 1
Trypanosoma cruzi cytochrome P450 reductase, putative 0.1588 1 1
Entamoeba histolytica type A flavoprotein, putative 0.0607 0 0.5
Entamoeba histolytica type A flavoprotein, putative 0.0607 0 0.5
Plasmodium falciparum nitric oxide synthase, putative 0.1588 1 1
Trypanosoma cruzi NADPH-dependent FMN/FAD containing oxidoreductase, putative 0.1588 1 1
Entamoeba histolytica type A flavoprotein, putative 0.0607 0 0.5
Schistosoma mansoni cytochrome P450 reductase 0.1588 1 1
Loa Loa (eye worm) hypothetical protein 0.1588 1 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 5.06 Inhibitory activity against prostaglandin G/H synthase 1 (COX-1) ChEMBL. 12383007
IC50 (binding) = 5.96 Inhibition of human Prostaglandin G/H synthase 2 ChEMBL. 11563921
IC50 (binding) = 5.96 Inhibitory activity against prostaglandin G/H synthase 2 (COX-2) ChEMBL. 12383007
IC50 (binding) = 1.09 uM Inhibitory concentration against human prostaglandin G/H synthase 2 at 25 degrees. ChEMBL. 11814774
IC50 (binding) = 1.09 uM In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2) ChEMBL. 9135032
IC50 (binding) = 1.09 uM Inhibitory concentration against human prostaglandin G/H synthase 2 at 25 degrees. ChEMBL. 11814774
IC50 (binding) = 1.09 uM In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2) ChEMBL. 9135032
IC50 (binding) = 8.8 uM In vitro inhibitory concentration required to block recombinant human prostaglandin G/H synthase 1 (COX-1) ChEMBL. 9135032
IC50 (binding) = 8.8 uM In vitro inhibitory concentration required to block recombinant human prostaglandin G/H synthase 1 (COX-1) ChEMBL. 9135032
Ki (binding) = 1.74 Inhibitory constant against prostaglandin G/H synthase 2 (COX-2) ChEMBL. 12383007
Ki (binding) = 9.13 Inhibitory constant against prostaglandin G/H synthase 1 (COX-1) ChEMBL. 12383007
Ki (binding) = 1.74 Inhibitory constant against prostaglandin G/H synthase 2 (COX-2) ChEMBL. 12383007
Ki (binding) = 9.13 Inhibitory constant against prostaglandin G/H synthase 1 (COX-1) ChEMBL. 12383007
Log IC50 (binding) = 5.06 Inhibitory activity against prostaglandin G/H synthase 1 (COX-1) ChEMBL. 12383007
Log IC50 (binding) = 5.96 Inhibition of human Prostaglandin G/H synthase 2 ChEMBL. 11563921
Log IC50 (binding) = 5.96 Inhibitory activity against prostaglandin G/H synthase 2 (COX-2) ChEMBL. 12383007
Selectivity (binding) = 0.907 Selectivity as log (IC50[COX-1]/IC50[COX-2]). ChEMBL. 12383007

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

4 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.